Keren Yizhak

Title: Keren Yizhak: Innovator in Immunotherapy

Introduction

Keren Yizhak is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of immunotherapy. With a focus on tumor infiltrating lymphocytes, her work aims to enhance the effectiveness of cancer treatments.

Latest Patents

Keren Yizhak holds a patent titled "Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof." This patent is directed towards CD8+ tumor infiltrating lymphocytes that comprise gene signatures associated with responses to immunotherapy treatment. The subject matter includes methods and compositions for utilizing these gene signatures, particularly in relation to checkpoint blockade therapy. Additionally, her patent outlines methods for using these gene signatures and immune cell subtypes, as well as pharmaceutical compositions that include populations of CD8+ TILs enriched for specific subtypes.

Career Highlights

Throughout her career, Keren has worked with esteemed organizations such as the General Hospital Corporation and the Broad Institute, Inc. Her innovative research has positioned her as a key figure in the development of immunotherapeutic strategies.

Collaborations

Keren has collaborated with notable colleagues, including Moshe Sade-Feldman and Gad Getz, contributing to advancements in her field.

Conclusion

Keren Yizhak's work in immunotherapy exemplifies the impact of innovative research on cancer treatment. Her patent and collaborations highlight her commitment to improving patient outcomes through scientific discovery.